A carregar...
Long‐term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses
OBJECTIVE: Generalized myasthenia gravis (gMG) is an autoimmune disease that causes disabling weakness via damage to the neuromuscular junction. In most patients, the disease is mediated by autoantibodies to the acetylcholine receptor, which activate the complement cascade. Our objective was to anal...
Na minha lista:
| Publicado no: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8283175/ https://ncbi.nlm.nih.gov/pubmed/34043280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51376 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|